Melissa R Snyder

Title: Melissa R Snyder: Innovator in Antibody Therapeutics

Introduction

Melissa R Snyder is a prominent inventor based in Rochester, MN (US). She has made significant contributions to the field of antibody therapeutics, holding 2 patents that showcase her innovative approaches to medical treatments. Her work is particularly focused on methods for quantifying monoclonal antibodies and treating various medical conditions.

Latest Patents

One of her latest patents is titled "Quantifying monoclonal antibody therapeutics by LC-MS/MS." This document relates to methods for quantifying antibody therapeutics using mass spectrometry techniques. Another notable patent is "Methods for treating medical conditions by anti-type 2 therapy." This patent provides methods and materials involved in treating medical conditions, such as using anti-Interleukin 4, anti-Interleukin 5, and/or anti-Interleukin 13 antibodies to treat asthma in mammals identified as having a Th2 immune response.

Career Highlights

Melissa R Snyder is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research and innovations in the field of antibody therapeutics. Her work has the potential to significantly impact the treatment of various medical conditions.

Collaborations

Some of her notable coworkers include David R Barnidge and Maria Alice Vieira Willrich, who contribute to her research efforts and collaborative projects.

Conclusion

Melissa R Snyder is a key figure in the development of innovative therapies for medical conditions, particularly through her work with monoclonal antibodies. Her patents reflect her commitment to advancing healthcare solutions and improving patient outcomes.